Development Level

Tbio 5 | 10,625

Disease

cystic fibrosis 3 | 1,665
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,956
intraductal papillary-mucinous neoplasm (IPMN) 3 | 3,289
lung cancer 3 | 4,466
osteosarcoma 3 | 7,933
ovarian cancer 3 | 8,484
psoriasis 3 | 6,685
subependymal giant cell astrocytoma 3 | 2,287
Cancer 2 | 2,346
Hypertrophic Cardiomyopathy 2 | 56
Metabolic syndrome X 2 | 155
diabetes mellitus 2 | 1,663
glioblastoma 2 | 5,572
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,988
primary Sjogren syndrome 2 | 789
sarcoidosis 2 | 358
tuberculosis 2 | 1,557
22q13.3 Deletion Syndrome 1 | 2
ADULT syndrome 1 | 9
Acanthosis nigricans 1 | 14
Acute kidney injury 1 | 65
Addison's disease 1 | 29
Albuminuria 1 | 20
Amenorrhea 1 | 60
Anemia 1 | 252
Anovulation 1 | 20
Autonomic neuropathy 1 | 21
Bipolar Disorder 1 | 266
Blindness 1 | 84
Brain disease 1 | 83
Cardiac arrest 1 | 26
Diabetes Mellitus, Insulin-Dependent 1 | 76
Diabetic Cardiomyopathies 1 | 10
Diabetic Nephropathy 1 | 37
Diabetic Retinopathy 1 | 53
Diarrhea 1 | 155
Donohue Syndrome 1 | 6
Dumping syndrome 1 | 9
Duodenal ulcer 1 | 20
Eating disorder 1 | 24
Edema 1 | 38
Exocrine pancreatic insufficiency 1 | 21
Fatty Liver 1 | 48
Fatty liver disease 1 | 84
Gout 1 | 93
Hailey-Hailey disease 1 | 10
Heart failure 1 | 80
Hepatitis 1 | 61
Hepatitis C 1 | 90
Hyperglycemia 1 | 120
Hyperinsulinemic hypoglycemia 1 | 17
Hyperinsulinism 1 | 63
Hyperparathyroidism 1 | 43
Hyperprolactinemia 1 | 22
Hyperthyroidism 1 | 50
Hypertriglyceridemia 1 | 18
Hyperuricemia 1 | 35
Hypoglycemia 1 | 81
Hypogonadism 1 | 70
Hypokalemia 1 | 40
Hypopituitarism 1 | 36
Hypotension 1 | 53
Impaired glucose tolerance 1 | 12
Impotence 1 | 45
Insulin Resistance 1 | 48
Insulinoma 1 | 20
Keratosis Follicularis 1 | 3
Lactic acidosis 1 | 42
Lewy Body Disease 1 | 19
Lipodystrophy 1 | 32
Liver Failure, Acute 1 | 22
Liver disease 1 | 219
Lupus erythematosus 1 | 80
Macular retinal edema 1 | 11
Maturity-Onset Diabetes of the Young, Type 1 1 | 2
Memory Disorders 1 | 36
Metabolic Diseases 1 | 9
Neural Tube Defects 1 | 27
Obstructive sleep apnea 1 | 28
Osteoporosis 1 | 257
Pancreatic agenesis 1 | 14
Pancreatitis 1 | 97
Panic disorder 1 | 55
Paralysed 1 | 9
Paresthesia 1 | 2
Parkinson Disease 1 | 102
Pemphigus 1 | 18
Plague 1 | 19
Prader-Willi syndrome 1 | 45
Renal Insufficiency 1 | 10
Thyrotoxicosis 1 | 38
Tularemia 1 | 22
Type 1 diabetes mellitus 1 | 101
Urinary Bladder Diseases 1 | 5
Ventricular Dysfunction, Left 1 | 15
Weight decreased 1 | 18
Wolfram syndrome 1 | 11
head and neck cancer and chronic obstructive pulmonary disease 1 | 237
maturity-onset diabetes of the young 1 | 28
protein-energy malnutrition 1 | 8

Tissue

Blood and immune system 5 | 17,995
Cardiovascular System 5 | 17,958
Digestive Tract 5 | 18,473
Endocrine System 5 | 18,512
Female tissues 5 | 18,647
Liver and Pancreas 5 | 18,136
Male tissues 5 | 17,969
Nervous System 5 | 18,561
Skin and soft tissues 5 | 18,115
Urinary Tract 5 | 18,444
Respiratory system 4 | 17,484

Target Family

Non-IDG 3 | 11,971
Enzyme 1 | 4,146
Transporter 1 | 473

Grant Application

5R01DK064315-10 5 | 5
3P41RR001209-23S1 157 | 157
5P41RR001209-22 157 | 157
5P41RR001209-23 157 | 157
2P51RR000165-51 139 | 139
5P51RR000163-52 136 | 136
5P51RR000163-51 132 | 132
5P51RR000165-50 130 | 130
2P51RR000163-50 128 | 128
5P51RR000164-48 127 | 127
5P51RR000164-50 125 | 125
5P51RR000164-49 112 | 112
5P51RR000165-49 106 | 106
5P41RR001646-19 103 | 103
5P41RR001646-20 103 | 103
7P51RR000163-41 100 | 100
2P41RR011823-16 99 | 99
5P51RR000163-42 98 | 98
5P51RR000163-43 98 | 98
5P41RR001081-24 94 | 94
5P41RR001646-18 90 | 90
5P41RR015301-09 82 | 82
5P51RR000167-49 78 | 78
5P41RR002250-26 65 | 65
5P51RR000168-40 65 | 65
5P51RR000168-41 65 | 65
5P41RR001646-27 64 | 64
5P51RR000165-40 63 | 63
5M01RR000188-45 60 | 60
3P41RR010888-05S1 59 | 59
5M01RR000030-40 58 | 58
5M01RR000096-39 57 | 57
5P41RR000954-25 57 | 57
5P41RR000954-26 57 | 57
2P41RR000954-33 56 | 56
5P41RR010888-14 56 | 56
5P41RR012408-13 55 | 55
5M01RR000188-46 53 | 53
5P41RR001646-28 52 | 52
5P51RR000167-48 52 | 52
5P51RR000168-49 52 | 52
5P41RR001646-29 51 | 51
2P41RR002250-25 50 | 50
5M01RR000188-47 50 | 50
5P51RR000166-39 47 | 47
5M01RR000043-40 46 | 46
5P51RR000168-50 46 | 46
5P41RR010888-15 45 | 45
5P41RR015301-08 45 | 45
5P41RR004050-13 44 | 44
5M01RR000847-37 43 | 43
5P41RR004050-12 43 | 43
5P51RR000167-50 43 | 43
5P51RR000169-50 43 | 43
5P41RR000954-34 42 | 42
2P41RR004050-21 41 | 41
5P41RR010888-13 41 | 41
5P51RR000168-48 41 | 41
5P51RR000167-40 40 | 40
5P41RR015301-07 39 | 39
5P51RR000164-39 39 | 39
5P51RR000168-39 39 | 39
2P51RR000169-49 38 | 38
5P51RR000169-48 38 | 38
5P41RR004050-23 37 | 37
5P51RR013986-13 37 | 37
3P51RR000167-46S2 36 | 36
5P41RR001008-25 36 | 36
5M01RR000043-49 35 | 35
5P20RR021905-04 35 | 35
5P41RR004050-22 35 | 35
5M01RR000040-40 34 | 34
5P20RR016481-10 34 | 34
5P41RR001315-19 34 | 34
3P60DE013079-01S1 32 | 32
5M01RR000833-26 32 | 32
5P20RR016481-11 32 | 32
5P20RR020152-07 32 | 32
5P41RR000862-38 32 | 32
5P51RR000166-49 32 | 32
5P60DE013079-02 32 | 32
5S06GM008037-29 32 | 32
5S06GM008037-30 32 | 32
5U41RR007707-10 32 | 32
2P20RR016480-09 31 | 31
5M01RR000827-34 31 | 31
5P41RR002250-24 31 | 31
5P41RR005959-22 31 | 31
5P41RR018522-08 31 | 31
3P60DE013079-03S1 30 | 30
5P20RR016457-10 30 | 30
5P41RR000592-40 30 | 30
5P41RR000592-41 30 | 30
5P41RR000862-36 30 | 30
5P41RR007707-17 30 | 30
5P51RR000166-48 30 | 30
5P60DE013079-03 30 | 30
5P60DE013079-04 30 | 30
5U54AI057168-09 30 | 30
5U54AI057168-10 30 | 30
2U54AI057168-06 29 | 29

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Insulin INS Tbio Non-IDG -5.14691 141255.4 1549
Calcium-transporting ATPase type 2C member 1 ATP2C1 Tbio Transporter -2.83846 694.7 205
Lymphocyte antigen 75 LY75 Tbio Non-IDG 202.3 425
Interferon-inducible protein AIM2 AIM2 Tbio Non-IDG -2.26799 140.7 401
Glucose-6-phosphatase 2 G6PC2 Tbio Enzyme -1.73455 81.3 34